NDC 51662-1216

50% DEXTROSE

50% Dextrose

50% DEXTROSE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dextrose Monohydrate.

Product ID51662-1216_763b1cb8-1152-5f59-e053-2991aa0a4e01
NDC51662-1216
Product TypeHuman Prescription Drug
Proprietary Name50% DEXTROSE
Generic Name50% Dextrose
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-09-19
Marketing CategoryNDA / NDA
Application NumberNDA019445
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameDEXTROSE MONOHYDRATE
Active Ingredient Strength25 g/50mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1216-1

1 SYRINGE, PLASTIC in 1 CARTON (51662-1216-1) > 50 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2018-09-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1216-1 [51662121601]

50% DEXTROSE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019445
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-19
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE MONOHYDRATE25 g/50mL

OpenFDA Data

SPL SET ID:763b1cb8-1151-5f59-e053-2991aa0a4e01
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 727517

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.